Help Center

Visit http://invest.trueleaf.com and click the “Invest Now” button in the navigation bar. Please make sure to read the offering circular here which details all the terms of this offering, before making an investment.

You are investing in True Leaf Medicine International Ltd. True Leaf Pet and True Leaf Medicine are two subsidiaries of the Canadian-based health and wellness company. While True Leaf Pet is dedicated to developing functional hemp-based pet products, True Leaf Medicine is a licensed producer applicant and has reached the final stage of becoming a supplier of medicinal cannabis products for both people and pets under the Canadian government’s legal Access to Cannabis for Medicinal Purposes Regulations (ACMPR).

The minimum investment is $350 CAD.

True Leaf is looking to raise $10 million. The funds will be used to grow the revenue of its subsidiary True Leaf Pet, and to advance the efforts of its subsidiary True Leaf Medicine to become a licensed producer of medicinal cannabis in Canada. 

Canadian and US residents can invest!  True Leaf is selling securities in the United States relying on Tier 2 of Regulation A under the Securities Act of 1933.  In Canada, True Leaf relies on the offering memorandum exemption under National Instrument 45-106.

True Leaf is the first cannabis-related public company to apply for Regulation A+ crowdfunding in the USA as of September 2017. True Leaf Medicine International Ltd. is publicly traded on Canada’s CSE, Germany’s FSE, and USA’s OTCQB.

The cannabis industry is a very dynamic industry that is garnering lots of attention from clients, investors, media and governments. In the US, cannabis remains federally illegal. In Canada, the federal government is planning to legalize marijuana in 2018. True Leaf sells legal hemp pet products in the US, Canada and globally. In Canada we are in the final phase of being approved as a licensed provider of medical marijuana.

The Securities and Exchange Commission (SEC) exists to protect investors and promote a market environment that is worthy of the public's trust. True Leaf has applied and met the stringent requirements of the SEC. We are proud the SEC has approved our Reg A+ offering and views this decision as an endorsement of the quality of our management and integrity of our company and product.

True Leaf is currently in the build out phase of the process to acquire a license to produce marijuana in Canada under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Once True Leaf successfully completes construction, the company can expect to be granted a license to cultivate cannabis and produce marijuana in Canada. Health Canada will then schedule an inspection to verify that True Leaf is meeting the requirements of the ACMPR, and if the company successfully completes that step, Health Canada will issue a license for True Leaf to sell cannabis products in Canada. The company filed an application in 2013 under the Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

The securities issued in Reg A+ will be unrestricted and freely transferable.

The Jumpstart Our Business Startups (JOBS) Act was signed into law by President Barack Obama on April 5, 2012, to encourage funding of small businesses by easing various securities regulations. The JOBS Act required the Securities and Exchange Commission (SEC) to adopt rules to implement a new exemption that would allow businesses to accept contributions from private individuals without making an initial public offering.

In June 2015, the final "Regulation A+" rules under Title IV of the JOBS Act became effective, after approval by the SEC, paving the way for companies like True Leaf to solicit their raise up to $50 million from both accredited and non-accredited investors.

"The SEC has qualified this offering" means the SEC has permitted True Leaf to offer for sale the securities described in the offering circular here to investors such as you. The SEC is not judging the merits, accuracy, or completeness of the offering and information in the offering circular. Rather, the SEC is merely ensuring True Leaf has met federal legal disclosure and regulatory requirements necessary to make these shares available to you.

US and Canadian citizens, accredited and non-accredited investors alike, are eligible to purchase securities in a Regulation A+ offering.

An accredited investor is an individual who makes over $200,000 per year ($300,000 if combined with a spouse) or who has a net worth of $1 million or more, excluding their primary residence. A non-accredited investor is anyone who does not meet the net worth requirements for an accredited investor.

Non-accredited investors can invest up to 10% of the greater of their annual income or net worth. There are no restrictions for accredited investors.